Literature DB >> 1904648

Management of the short-bowel syndrome.

S J Dudrick1, R Latifi, D E Fosnocht.   

Abstract

The patient with short-bowel syndrome after massive small-intestinal resection represents one of the greatest clinical challenges a general surgeon must face. Maintaining optimal nutritional and metabolic support until maximum bowel adaptation can occur is the top priority of therapy. Currently, no operative procedure for adjunctive management of the short-bowel syndrome is sufficiently safe and effective to recommend its routine use. Long-term parenteral nutrition remains the cornerstone of successful management.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904648     DOI: 10.1016/s0039-6109(16)45438-1

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

Review 1.  Small intestinal transplantation for irreversible intestinal failure in children.

Authors:  S A Kocoshis; J Reyes; S Todo; T E Starzl
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

2.  Factors predicting a successful outcome after pharmacologic bowel compensation.

Authors:  D W Wilmore; J M Lacey; R P Soultanakis; R L Bosch; T A Byrne
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

3.  The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats.

Authors:  Yan Gu; Zhao-Han Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

4.  Epidermal growth factor and neurotensin induce microvillus hypertrophy following massive enterectomy.

Authors:  C K Ryan; J H Miller; A S Seydel; K de Mesy Jensen; H C Sax
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

5.  A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet.

Authors:  T A Byrne; R L Persinger; L S Young; T R Ziegler; D W Wilmore
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.